Back
Flushing Financial Vs. Spyre Therapeutics Industry Stock Comparison
Sell
50
FFIC
Flushing Financial
Last Price:
14.09
Seasonality Move:
5.48%
Buy
59
SYRE
Spyre Therapeutics
Last Price:
28.46
Seasonality Move:
-2.85%
Sell
50
Flushing Financial (FFIC)
is a Sell
Is Flushing Financial a Buy, Sell or Hold?
- The current Flushing Financial [FFIC] share price is $14.10. The Score for FFIC is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- FFIC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
59
Spyre Therapeutics (SYRE)
is a Buy
Is Spyre Therapeutics a Buy, Sell or Hold?
- The current Spyre Therapeutics [SYRE] share price is $29.04. The Score for SYRE is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
- SYRE is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
FFIC Stock Price Chart
What is Flushing Financial's stock price today?
-
The Flushing Financial share price today is $14.10
The current trend is moderately bearish and FFIC is experiencing slight selling pressure.
SYRE Stock Price Chart
What is Spyre Therapeutics's stock price today?
-
The Spyre Therapeutics share price today is $29.04
The current trend is moderately bearish and SYRE is experiencing slight buying pressure.
FFIC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.14 | Buy |
Relative Strength Index (14 RSI): | 49.49 | Sell |
Chaikin Money Flow: | -51760 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (13.67 - 14.65) | Sell |
Bollinger Bands (100): | (12.33 - 14.63) | Buy |
SYRE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.41 | Buy |
Relative Strength Index (14 RSI): | 53.02 | Buy |
Chaikin Money Flow: | 71063 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (26.98 - 29.52) | Buy |
Bollinger Bands (100): | (25.44 - 33.84) | Sell |
FFIC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 14.55 | Sell |
20-day SMA: | 14.16 | Sell |
50-day SMA: | 14.17 | Sell |
200-day SMA: | 13.65 | Buy |
8-day EMA: | 14.31 | Sell |
20-day EMA: | 14.2 | Sell |
50-day EMA: | 13.95 | Buy |
200-day EMA: | 13.68 | Buy |
SYRE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 29.1 | Sell |
20-day SMA: | 28.66 | Buy |
50-day SMA: | 27.88 | Buy |
200-day SMA: | 29.31 | Sell |
8-day EMA: | 28.88 | Buy |
20-day EMA: | 28.56 | Buy |
50-day EMA: | 28.37 | Buy |
200-day EMA: | 27.36 | Buy |
Flushing Financial Earnings Growth & FFIC Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.05 per share, an increase next quarter of $0.12 per share, a decrease this year of $0.17 per share, and an increase next year of $0.34 per share.
Spyre Therapeutics Earnings Growth & SYRE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.05 per share, an increase next quarter of $0.24 per share, an increase this year of $9.51 per share, and an increase next year of $0.02 per share.
Flushing Financial Technical Analysis
Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Spyre Therapeutics Technical Analysis
Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |